0.0490
+0.0250
(104.17%)
Jun 19 - Close
OTCMKTS
data delayed by 15 mins -
Disclaimer
Currency in USD
| Range | 0.02 - 0.05 |
| 52 week | 0.01 - 0.30 |
| Open | 0.05 |
| Vol / Avg. | 11,800.00/8,433.00 |
| Mkt cap | 1.16M |
| P/E | - |
| Div/yield | - |
| EPS | -0.21 |
| Shares | 23.71M |
| Beta | 2.56 |
| Inst. own | 41% |
Key stats and ratios
| Q3 (Sep '10) | 2009 | |
| Net profit margin | 12.20% | 2.17% |
| Operating margin | 14.17% | 18.94% |
| EBITD margin | - | 20.51% |
| Return on average assets | 6.38% | 2.51% |
| Return on average equity | 11.84% | 3.91% |
| Employees | 281 | - |
| Carbon Disclosure Rating | - | - |
Address
Room 702, Guangri Mansion No. 9 Siyou Nan Road Alley 1, 1st Street
GUANGZHOU, GNG 510600
China
+86-20-87372102 (Phone)
GUANGZHOU, GNG 510600
China
+86-20-87372102 (Phone)
Website links
External links
Discussion Group - Google Finance
Advertisement
Description
China Medicine Corporation is a distributor of pharmaceutical and medical products in the People's Republic of China (PRC), including prescription and over-the-counter drugs, Chinese herbs, traditional Chinese medicines made from Chinese herbs, nutritional supplements, dietary supplements, and medical instruments. The Company is also engaged in research and development with the aim of creating new pharmaceutical products and intellectual property that it may sell in the future. During the year ended December 31, 2009, 99% of its total revenues came from product sales and 1% came from sales of intellectual property. Through Guangzhou Konzern Medicine Co., Ltd. (Konzern), the Company�s wholly owned subsidiary, it distributes approximately 2,100 products in China.
Officers and directors
| Senshan Yang | Chief Executive Officer, Director | |
| Chi Fung Ho | Chief Financial Officer, Vice President - Finance and Accounting | |
| Minhua Liu | Executive Vice President | |
| Rachel Gong | Independent Director | |
| Ian Grant Robinson | Independent Director | |
| Ryan J. Shih | Independent Director |